Department of Acute & Tertiary Care, University of Pittsburgh, School of Nursing, Pennsylvania, USA.
J Cardiovasc Nurs. 2011 May-Jun;26(3):210-7. doi: 10.1097/JCN.0b013e31820017dc.
Currently 23.5 million working-age adults 20 years or older have had a diagnosis of both coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM), with estimates that an additional 9% of the total US population will have a diagnosis of this chronic disease combination by the year 2025. Current annual health care costs for this working-age population including medical costs, functional disability, work loss, and premature mortality currently exceed $620 billion. Prior research efforts have shown that 25% to 32% of patients requiring a coronary revascularization procedure have both CAD and T2DM. The primary intervention prescribed for these patients to regain functional ability after revascularization is enrollment in a standard outpatient cardiac rehabilitation (CR) program. These standard programs, ranging in duration from 6 to 12 weeks, have been shown to improve the physical function of CAD patients by up to 15%, but patients diagnosed with both chronic conditions of CAD and T2DM (T2DM+CAD) attending these same programs exhibit only an 8% improvement. Moreover, T2DM+CAD patients experience much lower rates of rehabilitation program appointment adherence as well as greater program attrition (T2DM+CAD: 45%-62% vs CAD: 92%). Current medical literature regarding the relationship between CAD, T2DM, and cardiac rehabilitation will be examined to identify specific factors that could influence the functional outcomes achieved by the T2DM+CAD population when enrolled in a standard CR program and help increase understanding of why the adherence and attrition differences exist.
目前,有 2350 万 20 岁或以上的劳动年龄成年人被诊断患有冠状动脉疾病 (CAD) 和 2 型糖尿病 (T2DM),估计到 2025 年,美国总人口中将有另外 9%被诊断出患有这种慢性疾病组合。目前,该劳动年龄人群的年度医疗保健费用包括医疗费用、功能障碍、工作损失和过早死亡,超过 6200 亿美元。先前的研究表明,需要进行冠状动脉血运重建手术的患者中有 25%至 32%同时患有 CAD 和 T2DM。为这些患者在血管重建后恢复功能而规定的主要干预措施是参加标准的门诊心脏康复 (CR) 计划。这些标准计划持续时间从 6 周到 12 周不等,已被证明可以使 CAD 患者的身体功能提高高达 15%,但参加这些相同计划的同时患有 CAD 和 T2DM 这两种慢性疾病的患者(T2DM+CAD)仅提高 8%。此外,T2DM+CAD 患者的康复计划预约坚持率和计划流失率(T2DM+CAD:45%-62%比 CAD:92%)要低得多。目前将检查关于 CAD、T2DM 和心脏康复之间关系的医学文献,以确定影响 T2DM+CAD 人群在参加标准 CR 计划时获得的功能结果的具体因素,并帮助更好地理解为什么会存在坚持和流失差异。